Anika Therapeutics, Inc. (ANIK)

NASDAQ: ANIK · Real-Time Price · USD

19.58

+0.35 (1.82%)

At close: Oct 9, 2026, 4:00 PM EDT

19.57

-0.01 (-0.05%)

After-hours: Oct 9, 2026, 7:30 PM EDT

Anika Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	262	139	241	332	432	517
Market Cap Growth	96.73%	-42.51%	-27.34%	-23.28%	-16.40%	-19.60%
Enterprise Value	249	105	206	290	376	447
Last Close Price	19.58	9.61	16.46	22.66	29.60	35.83

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	125.13
Forward PE	17.18	53.39	39.19	72.08	72.08	112.55
PS Ratio	2.17	1.23	2.01	2.75	3.80	3.50
PB Ratio	1.91	0.97	1.57	1.56	1.51	1.80
P/TBV Ratio	2.05	1.04	1.67	1.64	2.12	2.63
P/FCF Ratio	466.26	31.77	-	-	-	158.96
P/OCF Ratio	43.84	12.39	44.62	-	98.08	61.60
PEG Ratio	1.72	11.40	1.96	3.60	3.60	161.40

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.06	0.93	1.72	2.40	3.30	3.03
EV/EBITDA Ratio	81.87	-	172.87	45.74	41.04	194.39
EV/EBIT Ratio	-	-	-	344.10	102.39	-
EV/FCF Ratio	442.84	24.10	-	-	-	137.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.18	0.18	0.17	0.13	0.11	0.07
Debt / EBITDA Ratio	8.31	-	5.25	2.75	2.49	4.12
Debt / FCF Ratio	44.93	6.02	-	-	-	6.44
Net Debt / Equity Ratio	-0.10	-0.22	-0.19	-0.19	-0.19	-0.26
Net Debt / EBITDA Ratio	-4.33	5.71	-24.89	-6.46	-6.05	-31.90
Net Debt / FCF Ratio	-23.42	-7.16	12.74	5.68	18.02	-22.57
Asset Turnover	0.65	0.57	0.51	0.39	0.33	0.41
Inventory Turnover	2.01	2.30	1.80	1.19	1.07	1.42
Quick Ratio	3.05	3.71	3.40	3.06	4.33	4.17
Current Ratio	4.48	4.72	4.88	5.26	6.07	5.66
Return on Equity (ROE)	-2.19%	-6.71%	-4.82%	-1.38%	0.77%	1.48%
Return on Assets (ROA)	-0.87%	-3.52%	-1.19%	0.17%	0.66%	-2.11%
Return on Invested Capital (ROIC)	-2.14%	-9.35%	-3.04%	-0.46%	0.84%	-5.86%
Return on Capital Employed (ROCE)	-1.60%	-6.60%	-2.50%	0.40%	1.10%	-3.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-1.44%	-7.85%	-23.39%	-24.92%	-3.44%	0.80%
FCF Yield	0.21%	3.15%	-0.97%	-2.17%	-0.71%	0.63%
Buyback Yield / Dilution	4.23%	2.60%	-0.44%	-0.65%	0.50%	-2.90%

SEC Filings: 10-K · 10-Q